Cellosaurus cell line 3E9 [Mouse hybridoma against marinobufagenin] (CVCL

Cellosaurus 3E9 [Mouse hybridoma against marinobufagenin] (CVCL_B0LA)

Cross-references
Cell line name	3E9 [Mouse hybridoma against marinobufagenin]
Synonyms	MBG3E9
Accession	CVCL_B0LA
Resource Identification Initiative	To cite this cell line use: 3E9 [Mouse hybridoma against marinobufagenin] (RRID:CVCL_B0LA)
Comments	Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6724. Monoclonal antibody isotype: IgG1. Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG). Misspelling: MGB3E9; ATCC=PTA-6724.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_2199 (Sp2/0-Ag14)
Category	Hybridoma
Publications	PubMed=19008721; DOI=10.1097/HJH.0b013e328312c86a; PMCID=PMC2583455 Olga V. Fedorova, Andrey Semenovich Simbirtsev, Nikolai I. Kolodkin, Alexander Y. Kotov, Natalia I. Agalakova, Vladimir A. Kashkin, Natalia I. Tapilskaya, Anton Bzhelyansky, Vitaly A. Reznik, Elena V. Frolova, Elena R. Nikitina ...Show all 15 authors... , Georgy V. Budny, Dan Louis Longo, Edward G. Lakatta, Alexei Y. Bagrov; Show fewer authors Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension. J. Hypertens. 26:2414-2425(2008) Patent=US8038997 Alexei Y. Bagrov, Olga V. Fedorova, Edward G. Lakatta, Andrey Semenovich Simbirtsev, Alexander Y. Kotov, Nikolai I. Kolodkin; Anti-marinobufagenin antibodies and methods for their use. Patent number US8038997, 18-Oct-2011
Cell line collections (Providers)	ATCC; PTA-6724 - Discontinued
Encyclopedic resources	Wikidata; Q108819602
Entry history
Entry creation	23-Sep-2021
Last entry update	19-Dec-2024
Version number	6